Investegate |MGC Pharmaceuticals Announcements | MGC Pharmaceuticals: ArtemiC Update investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Karnataka Covid lockdown news live: Covaxin trial on kids in Mysuru hospital
Karnataka Covid lockdown news live: Covaxin trial on kids in Mysuru hospital
Covid recovery rate in eight districts, including Belagavi, Bengaluru Urban and Rural, is less than Karnataka’s average of 81%, and this trend is driven largely by a frightening surge in number of fresh positive cases in recent weeks. While Belagavi has the lowest recovery rate in the state at 69% as of May 24, Bengaluru Rural and Urban have logged in 69.8% and 79%, respectively. Bidar has the highest at 95.4%. Stay with TOI for all updatesRead Less
THE TIMES OF INDIA | May 27, 2021, 11:50:34 IST
MGC Pharmaceuticals’ “historic” March quarter highlighted by LSE listing and record sales
MGC Pharma became the first medicinal cannabis company to list on the London Stock Exchange, amid record sales of its phytomedicines. CEO Roby Zomer says the company is now ready to capitalise on years of hard work.
MGC Pharmaceuticals Ltd (ASX:MXC) (LON:MXC) (OTCMKTS:MGCLF) (FRA:H5O) has completed arguably its best-ever quarter, with a London Stock Exchange (LSE) listing and record sales highlighting a busy period.
The European-based biopharma company, developing and producing phytocannabinoid-derived medicines, released its March quarterly report this morning.
It also gained Ethics Committee approval for a Phase III trial to evaluate the efficacy and safety of its COVID-19 drug, CimetrA™, expanded its pre-clinical brain cancer study and locked in additional funding.
MGC Pharmaceuticals Ltd poised to supply global phytocannabinoid market with growing patient base and global distribution footprint proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.